The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.
SBC: Leukogene Therapeutics Inc. Topic: 102
Project Summary Abstract Multiple MyelomaMMis the second most common form of blood cancer and remains an incurable and deadly diseaseProteasome inhibitorPItherapy is a cornerstone in the treatment of MMbut resistance to this class of agent is an emerging challenge in the clinicNew therapeutic approaches that specifically target resistance are needed to maximize responses and ultimately produce cur ...STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
SBC: Floreo, Inc. Topic: 103
Floreo Technology proposes to develop the Police Safety ModulePSMan innovativeimmersive mobile virtual realityVRapplication designed to train police safety in adolescents and adults with autism spectrum disorderASDASD has been increasing in prevalence over recent yearsWhile much attention has been paid to the causes and early diagnosis of ASDthere remains a clear need for effective interventions f ...STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health